State Street
CTOR

State Street’s Citius Oncology CTOR Stock Holding History

State Street’s Portfolio CTOR Stock Details CTOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.9K Hold
42,900
– – ﹤0.01% 4108
2026
Q1 		$26.6K Hold
42,900
– – ﹤0.01% 4194
2025
Q4 		$42.9K Hold
42,900
– – ﹤0.01% 4179
2025
Q3 		$87.1K Buy
+42,900
New +$92.9K ﹤0.01% 4076

Other funds holding CTOR

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

State Street's CTOR Position: Q2 2026 in Review

State Street held its Citius Oncology (CTOR) position steady in Q2 2026 at 42,900 shares worth $27.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4108.

State Street first reported a position in CTOR in Q3 2025 and has held it in 4 quarters since. The position peaked at $87.1K in Q3 2025. 19 funds tracked by Wall St. Rank hold CTOR as of Q2 2026.

  • State Street held 42,900 shares of Citius Oncology worth $27.9K as of Q2 2026.
  • State Street left its Citius Oncology share count unchanged in Q2 2026.
  • Citius Oncology made up ﹤0.01% of State Street's portfolio in Q2 2026, its #4108 holding.
  • State Street first reported a position in Citius Oncology in Q3 2025 and has held it in 4 quarters since.
  • State Street's Citius Oncology position peaked at $87.1K in Q3 2025.
  • 19 funds tracked by Wall St. Rank held Citius Oncology as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.